Sumitomo Pharma announces availability of ORGOVYX in Canada
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The company will provide comprehensive response to USFDA for the observations
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
ANVISA issues CGMP to Concord Biotech’s Unit I
Acquisition of exclusive commercialization rights for European markets
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Subscribe To Our Newsletter & Stay Updated